⌘K

Login Start Free

Home/Filings/4/0001213900-25-097178

4//SEC Filing

Szot Matthew K 4

Accession 0001213900-25-097178

CIK 0001937993other

View on SEC.gov Company Profile

Filed

Oct 6, 8:00 PM ET

Accepted

Oct 7, 8:22 PM ET

Size

4.8 KB

Accession

0001213900-25-097178

Insider Transaction Report

Form 4

Period: 2025-10-06

Cadrenal Therapeutics, Inc.CVKD

Chief Financial Officer

Transactions

Sale
Common Stock
2025-10-06$13.99/sh−107$1,497→ 17,026 total

Footnotes (1)

[F1]Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Cadrenal Therapeutics, Inc.

CIK 0001937993

Entity typeother

Related Parties

1

filerCIK 0001401385

Filing Metadata

Form type: 4
Filed: Oct 6, 8:00 PM ET
Accepted: Oct 7, 8:22 PM ET
Size: 4.8 KB

View on SEC.gov